<DOC>
	<DOCNO>NCT01020110</DOCNO>
	<brief_summary>Evaluation fibrin platelet deposition human umbilical endothelial cell surface perfusion chamber experiment use human whole blood . Open-label , non interventional study Perfusion chamber experiment perform 30 healthy patient . The Impact different pH-solutions thrombus lysis evaluate in-vitro second step Outcome : D-Dimer content thrombus reflect size thrombus .</brief_summary>
	<brief_title>Study Ex-vivo Thrombosis Model With Human Umbilical Vein Endothelial Cells ( HUVEC ) -Perfusion</brief_title>
	<detailed_description>All Subjects two perfusion chamber experiment follow estimate maximum blood loss 165ml : Before blood perfusion , perfuse system include chamber human umbilical vein endothelial cell coat glass slide ( HUVEC ) , sodium chloride ( NaCl ) ( 0.9 % ) , ensure leak remove air bubble . Blood drawn vein arm Surflo® Winged Infusion Set , 19G ( Terumo Europe , Leuven , Belgium ) pump ( Masterflex® L/S™ , Cole-Parmer Instrument Company , Vernon Hills , Illinois , USA ) . Five mL blood discard perfusion . Three serial place flow chamber ( HUVEC ) heat 37°C use . They make Plexiglas block cylindrical hole 0.2 cm diameter machine . The aorta piece perfuse 10 mL/min 5 minute , follow 30 second perfusion NaCl ( 0.9 % ) . The plasmin degrade thrombus D-Dimer content evaluate different condition ( different pH solution ) .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<criteria>Age &gt; 18 year Written inform consent Use medication Current diseases Anemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>perfusion chamber</keyword>
	<keyword>thrombus D-Dimer</keyword>
	<keyword>HUVEC</keyword>
</DOC>